ADM |
admission |
ACE2 |
angiotensin-converting enzyme 2 |
BP |
blood pressure |
CVD |
cardiovascular disease |
COVID-19 |
coronavirus disease 2019 |
DBP |
diastolic blood pressure |
DPP-4 |
dipeptidyl peptidase-4 inhibitor |
ED |
emergency department |
GIH |
glucocorticoid-induced hyperglycaemia |
GLP-1 |
glucagon-like peptide 1 |
HDL-C |
high-density lipoprotein cholesterol |
LDL-C |
low-density lipoprotein cholesterol |
Long-COVID |
long-coronavirus disease |
n
|
sample size |
NADPH |
reduced nicotinamide adenine dinucleotide phosphate |
p
|
p-value |
post-COVID |
post-coronavirus disease |
PTMs |
post-translational protein modifications |
RAAS |
renin-angiotensin-aldosterone system |
ROS |
reactive oxygen species (ROS) |
RT-PCR |
real-time reverse-transcriptase polymerase chain reaction |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus 2 |
SD |
standard deviation |
SETDB2 |
SET Domain Bifurcated Histone Lysine Methyltransferase 2 |
SBP |
systolic blood pressure |
VLDL-C |
very low-density lipoprotein cholesterol |